How should we manage patients with non-alcoholic fatty liver disease in 2007?
10.1111/j.1440-1746.2007.04977.x
Saved in:
Main Authors: | Chan, H.L.-Y., De Silva, H.J., Leung, N.W.-Y., Lim, S.-G., Farrell, G.C. |
---|---|
Other Authors: | MEDICINE |
Format: | Review |
Published: |
2016
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/131815 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
The Effect of Diabetes and Prediabetes on the Prevalence, Complications and Mortality in Non-alcoholic Fatty Liver Disease.
by: Ng, Cheng Han, et al.
Published: (2022) -
An Improved qFibrosis Algorithm for Precise Screening and Enrollment into Non-Alcoholic Steatohepatitis (NASH) Clinical Trials
by: Leow, W.-Q., et al.
Published: (2021) -
Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: a cross-sectional study of a random population sample aged 18 to 65 years
by: Ludwig, Ulla, et al.
Published: (2015) -
Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study.
by: Tan, Eunice Xiang-Xuan, et al.
Published: (2021) -
PROTECTIVE EFFECT OF FTO ABLATION AGAINST PALMITIC ACID-INDUCED LIPOTOXICITY IN NASH
by: LIM ANDREA
Published: (2016)